Abstract
Helicobacter pylori is probably the commonest bacterial infection of humans. The infection is likely to be acquired in childhood, 1 and in the developing world the incidence of infection in infancy may be up to 50%. 2 The rate of new infections in adults in developed countries is low, 3 and therefore an understanding of the epidemiology and transmission of H pylori infection requires studies to be conducted in children.
The methods of detection of H pylori infection in children are the same as in adults and can broadly be divided into invasive and non-invasive. Invasive methods involve endoscopy and gastric mucosal biopsy with detection of the organism by Campylobacter like organism (CLO) testing, microscopic examination of histological sections, or bacterial culture. Invasive methods are not suitable for large scale population studies.
Non-invasive tests rely either on the detection of gastric bacterial urease activity or on a serological response to the bacterium. There have been numerous serological studies performed in children, and the 13 C urea breath test (UBT) has recently been shown, in an epidemiological study in children, to be an alternative to serology and mucosal biopsy. 2 Another non-invasive test has recently been developed, which relies on the detection, by enzyme immunoassay, of H pylori antigens in the faeces. The test has hitherto been tested only in adults, 4 but owing to its non-invasive nature it may be suitable for both individual and population studies in children. The aim of the present study was firstly to evaluate the sensitivity and specificity of the new enzyme immunoassay (EIA) test compared with 13 C UBT, and secondly to determine the bacteriological specificity of the test.
Materials and methods

SUBJECTS
All children undergoing a UBT at the Royal Hospital for Sick Children, Glasgow as part of their routine investigation were invited to participate in the study. A total of 119 children were recruited (72 boys and 47 girls; mean age 10.4 years, range 3.9-18.4). No children who had received antibiotics, H 2 receptor antagonists, or proton pump inhibitors during the three weeks prior to testing were enrolled. The children all provided a faecal sample within seven days of the UBT by mailing a small sample in a clean universal container to the principle investigator. 13 
C UREA BREATH TEST
After an overnight fast each child ingested an oral dose of 100 mg 13 C urea (99 atom % excess, CK Gas, Berks, UK), administered in 20 ml of 15% Polycose (Abbot Labs, Dublin, Eire). Baseline breath samples were collected by asking the child to blow with a straw into a vacutainer, before and at 30 and 45 minutes after ingestion of the labelled urea. 13 C enrichment of breath was determined by isotope ratio mass spectrometry; a rise in 13 C enrichment of more than 66.0 ppm above fasting baseline (relative to a Pee Dee Belemnite (PDB) standard) was regarded as diagnostic of H pylori infection.
ENZYME IMMUNOASSAY
An enzyme immunoassay (Premier Plantinum HpSA, Meridian Diagnostics Inc., Cincinnati, Ohio, USA) was used to detect H pylori in the stool. It utilises an immunoaYnity purified polyclonal anti-H pylori rabbit antibody absorbed to microwells. Faecal specimens were stored at −70°C until the test was performed. Diluted faecal samples and a peroxidase conjugated polyclonal antibody were added to the wells and incubated for one hour at 24°C. The wells were washed to remove any unbound material, and a substrate was added before a further 10 minutes of incubation. A stop solution was then added and absorbance was measured spectrophotometrically at 450 nm. The results were assigned to positive, negative, or equivocal groups on the basis of the manufacturer's recommended cut oV values.
CROSS REACTIVITY STUDIES
National collection of type cultures (NCTC) strains of Helicobacter which are closely related to H pylori were used in cross reactivity experiments. They were H mustelae, H canis, H felis, H acinonyx, H pamatensis, H cinaedii, and H fenneliae. All of the organisms were cultured microaerophilically (BBL Campypak) for 48 hours at 37°C in brain heart infusion (BHI) broth supplemented with 5% vol/vol yeast extract and 1% vol/vol horse serum. At 48 hours decimal dilutions of the broths were made in BHI broth from 10 −1 to 10 −6
. The dilutions were mixed with an equal volume of faeces, which had previously been shown to be antigen negative by EIA. Bacterial cultures not mixed with faeces and negative faeces with no added bacteria were tested simultaneously.
The study was approved by the Ethics Committee at the Royal Hospital for Sick Children, Glasgow and performed with informed parental consent. The results were analysed using 2 analysis using the manufacturers, cut oVs for the EIA result. Sensitivity, specificity, positive, and negative predictive values were calculated using standard methods.
Results
A total of 119 children were tested using the UBT and EIA, and results were available from all (fig 1) . Analysis employed a UBT cut oV of 66.0 ppm excess 13 C and an EIA spectrophotometric absorbance cut oV of <0.14 negative, >0.16 positive, and >0.14 to <0.16 as an equivocal result as recommended by the manufacturers.
Twenty three children were positive and 73 were negative by both UBT and EIA. A further 17 were UBT negative but EIA positive whereas only two were UBT positive and EIA negative. Of the four equivocal EIA results only one was UBT positive. The sensitivity and specificity were calculated as 88% and 82% respectively at a cut oV of 0.16, with the positive predictive value of a result >0.16 being 58% and a negative predictive value of a result <0.14 being 97%.
BACTERIOLOGICAL STUDIES
In addition to the bacteriological specificity studies described by the manufacturer, the further cross reactivity of the test was assessed using the range of Helicobacter spp. listed in the methods section. H felis and H acinonyx showed a positive reaction to a dilution of 10 −4 when assayed by the EIA. All others showed no cross reactivity at all dilutions.
Discussion
The EIA has been shown to be a useful non-invasive diagnostic test for H pylori in children. Using the manufacturer's cut oV we calculate the sensitivity and specificity of the test to be 88% and 82% respectively compared with 13 C UBT and found the test to have positive and negative predictive values of 58% and 97%. The assay has only recently been made available and this is one of the first published evaluations in children. In previous studies in adults, sensitivity ranged from 89% 5 to 96%, 6 7 and specificity from 75% 7 to 100%. 8 To validate the EIA we compared it to the 13 C UBT. The diagnosis of H pylori infection can be based on endoscopy with biopsy and culture, but the 13 C UBT is also a sensitive indicator of the presence of the bacterium in the stomach and compares well with invasive testing. 9 We have validated it against mucosal biopsy in a small group of young children, and also developed a statistical method of interpreting the results of the UBT within a large population of infected children. 10 Most epidemiological studies have been performed using serology, which is less sensitive and specific than the UBT. 11 When our results from the EIA were compared with commercial serological tests it was clear that while the positive predictive value of the EIA at 58% was lower than serological tests, which range from 87% to 100%, 12 the negative predictive value was equal to the best of the kits (range 80-100%).
Colonisation with H pylori does not necessarily indicate disease; and tests with a high negative predictive value are useful to exclude infection whereas those with high positive predictive values indicate the need for further investigation. It is important to note that the negative predictive value depends on the cut oV value chosen. We used the manufacturer's cut oV which is based on adult studies. If the test is used to screen patients, then choosing a cut oV to maximise the negative predictive value may be appropriate.
A test which detects H pylori antigen in faeces may be of particular use in paediatric studies where non-invasive tests are preferred, and where obtaining blood samples may prove difficult. The EIA also has several potential advantages over the UBT for population studies. Firstly, patients are not required to attend hospital as faecal specimens can be transported or posted to the laboratory. Secondly, no expensive instrumentation or expertise is required to perform a standard enzyme linked immunosorbent assay (ELISA) test. It is possible that delay between collection and analysis of stool might account for the lower sensitivity and specificity of the test that we have found compared to adult studies.
Our study did not include patients treated with antimicrobials or proton pump inhibitors, or those with diarrhoea. It is therefore not possible to comment on the eVect that these factors may have on the EIA result. It is diYcult to quantify the clinical significance of the cross reaction with H acinonyx and H felis. H acinonyx is genetically very closely related to H pylori, 13 but there have been no reported cases of human infection. H felis has been shown to cause human disease 14 and there was speculation that domestic cats might play a role in the transmission of infection, 15 but a recent study suggests that owning pets is not a risk factor. 16 What, then, is the place of the EIA in the diagnosis and management of H pylori infection? The definitive diagnosis of disease caused by H pylori requires endoscopy. The UBT indicates the presence or absence of the organism in the stomach and is most appropriately used to confirm successful eradication of infection. With its high negative predictive value, ease of use, and non-invasive nature, the EIA is useful as a screening tool to exclude infection.
The detection of its antigens in stool supports the hypothesis that H pylori is excreted in the faeces and might be the principle mode of transmission. However, stool antigen may be a product of digestion of the organism residing in the stomach. Therefore, other than two reports of culture from the stool, 17 18 there is little evidence that H pylori survives passage through the gut. Nevertheless, detection of H pylori antigens in the stool is likely to drive researchers with new determination to culture the organism from faeces, and to try to characterise the form in which it exists in, or passes through the large bowel. 19 Therefore, in addition to its possible role as a diagnostic tool, the detection of stool antigens raises the possibility of genotyping the organism and thereby studying its transmission and epidemiology.
